• / Free eNewsletters & Magazine
  • / My Account
Home>Regions>Iceland

Iceland

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  6. Research
  1. Merck Receives Positive CHMP Opinion for Investigational Antibiotic ZERBAXA™ (Ceftolozane and Tazobactam)

    Merck Receives Positive CHMP Opinion for Investigational Antibiotic ZERBAXA™ (Ceftolozane and Tazobactam)

  2. AcelRx Announces Positive CHMP Opinion for Zalviso in the Management of Acute Moderate-to-Severe Post-Operative Pain in Adult Patients

    AcelRx Announces Positive CHMP Opinion for Zalviso in the Management of Acute Moderate-to-Severe Post-Operative Pain in Adult Patients

  3. Alterra Power Announces Release Date for the Second Quarter 2015 Results and Annual and Special Meeting Results

    Alterra Power Announces Release Date for the Second Quarter 2015 Results and Annual and Special Meeting Results

  4. European Commission Approves Amgen's New Cholesterol-Lowering Medication Repatha™ (evolocumab), The First PCSK9 Inhibitor To Be Approved In The World, For Treatment Of High Cholesterol

    European Commission Approves Amgen's New Cholesterol-Lowering Medication Repatha™ (evolocumab), The First PCSK9 Inhibitor To Be Approved In The World, For Treatment Of High Cholesterol

  5. Research and Markets: Global Food Blender & Mixer Market 2015-2020 - High Shear, Shaft, Ribbon Mixer, Double Cone, Planetary Mixer, Screw Mixer & Blenders

    Research and Markets: Global Food Blender & Mixer Market 2015-2020 - High Shear, Shaft, Ribbon Mixer, Double Cone, Planetary Mixer, Screw Mixer & Blenders

  6. UPDATE: Market top? Not with these tech earnings

    UPDATE: Market top? Not with these tech earnings

  7. UPDATE: This was the week the European dream died its deserved death

    UPDATE: This was the week the European dream died its deserved death

  8. Research and Markets: European Parcels Market Insight Report 2015

    Research and Markets: European Parcels Market Insight Report 2015

  9. HETLIOZ® Receives European Commission Approval for the Treatment of Non-24-Hour Sleep-Wake Disorder in the Totally Blind

    HETLIOZ® Receives European Commission Approval for the Treatment of Non-24-Hour Sleep-Wake Disorder in the Totally Blind

  10. Alterra Power and Starwood Energy Secure Loan Facility for the Shannon Wind Project

    Alterra Power and Starwood Energy Secure Loan Facility for the Shannon Wind Project

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.